Effective October 15th, the New York Medicare administrator, NGS, added STELARA® J3357 (pre-filled syringe and 45-mg vial) to their Self-Administered Drug list. This change means that patients receiving Stelara injections are not able to have these services covered under Medicare Part B.
Specialty Infusion is working with QuickRx pharmacy to service Medicare patients that are impacted by this change and provide continuity of care at our locations under Medicare Part D. We are also able to accommodate new Medicare patients that have been displaced from their normal injection site. Please contact us or have your physician prescribe here to QuickRx if you are interested in receiving Stelara injections at our Specialty Infusion locations.
Why Use Specialty Infusion Centers?
Featured Patient Testimonials
“The staff was top notch. Very friendly and accommodating. The level of cleanliness was superb.”
– Christoper H. via Google
“Feels more like going to the spa! Lovely, smart staff and super calming environment!”
– Laura H. via Facebook